Management of Latent Tuberculosis Infection

Management of Latent Tuberculosis Infection

This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2023-02, Vol.329 (5), p.421-422
Hauptverfasser: Kim, Steven, Thal, Rebecca, Szkwarko, Daria
Format: Artikel
Sprache:eng
Schlagworte:
Antitubercular Agents - therapeutic use
Cardiovascular diseases
Estrogens
Humans
Latent Tuberculosis - drug therapy
Menopause
Mycobacterium tuberculosis
Night
Paroxetine
Signs and symptoms
Therapy
Tuberculosis
Venlafaxine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 422
container_issue 5
container_start_page 421
container_title JAMA : the journal of the American Medical Association
container_volume 329
creator Kim, Steven
Thal, Rebecca
Szkwarko, Daria
description This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.
doi_str_mv 10.1001/jama.2022.24362
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2767169576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2800774</ama_id><sourcerecordid>2767169576</sourcerecordid><originalsourceid>FETCH-LOGICAL-a385t-bc0fb2b0c242fd3c2b84814857408acaae14fae1537e6279ff49a11f10df3bd33</originalsourceid><addsrcrecordid>eNpdkEtLAzEQgIMotlbPggcpeBFk27yTPUrxUVjxUs8hySayZXdTN7sH_71Z23pwDjMD880wfABcI7hAEKLlVjd6gSHGC0wJxydgihiRGWG5PAVTCHOZCSrpBFzEuIUpEBHnYEI4ZzwxU_Dwplv96RrX9vPg54Xux24zGNfZoQ6xivN1653tq9BegjOv6-iuDnUGPp6fNqvXrHh_Wa8ei0wTyfrMWOgNNtBiin1JLDaSSkQlExRKbbV2iPqUGBGOY5F7T3ONkEew9MSUhMzA_f7urgtfg4u9aqpoXV3r1oUhKiy4QDxngif07h-6DUPXpu8SlYIzRnGilnvKdiHGznm166pGd98KQTV6VKNHNXpUvx7Txu3h7mAaV_7xR3EJuNkD4-JxiiWEQlDyA3w-dSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2777765542</pqid></control><display><type>article</type><title>Management of Latent Tuberculosis Infection</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Kim, Steven ; Thal, Rebecca ; Szkwarko, Daria</creator><creatorcontrib>Kim, Steven ; Thal, Rebecca ; Szkwarko, Daria</creatorcontrib><description>This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2022.24362</identifier><identifier>PMID: 36656598</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Antitubercular Agents - therapeutic use ; Cardiovascular diseases ; Estrogens ; Humans ; Latent Tuberculosis - drug therapy ; Menopause ; Mycobacterium tuberculosis ; Night ; Paroxetine ; Signs and symptoms ; Therapy ; Tuberculosis ; Venlafaxine</subject><ispartof>JAMA : the journal of the American Medical Association, 2023-02, Vol.329 (5), p.421-422</ispartof><rights>Copyright American Medical Association Feb 7, 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a385t-bc0fb2b0c242fd3c2b84814857408acaae14fae1537e6279ff49a11f10df3bd33</citedby><cites>FETCH-LOGICAL-a385t-bc0fb2b0c242fd3c2b84814857408acaae14fae1537e6279ff49a11f10df3bd33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2022.24362$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.24362$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,315,781,785,3341,27929,27930,76494,76497</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36656598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Steven</creatorcontrib><creatorcontrib>Thal, Rebecca</creatorcontrib><creatorcontrib>Szkwarko, Daria</creatorcontrib><title>Management of Latent Tuberculosis Infection</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.</description><subject>Antitubercular Agents - therapeutic use</subject><subject>Cardiovascular diseases</subject><subject>Estrogens</subject><subject>Humans</subject><subject>Latent Tuberculosis - drug therapy</subject><subject>Menopause</subject><subject>Mycobacterium tuberculosis</subject><subject>Night</subject><subject>Paroxetine</subject><subject>Signs and symptoms</subject><subject>Therapy</subject><subject>Tuberculosis</subject><subject>Venlafaxine</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLAzEQgIMotlbPggcpeBFk27yTPUrxUVjxUs8hySayZXdTN7sH_71Z23pwDjMD880wfABcI7hAEKLlVjd6gSHGC0wJxydgihiRGWG5PAVTCHOZCSrpBFzEuIUpEBHnYEI4ZzwxU_Dwplv96RrX9vPg54Xux24zGNfZoQ6xivN1653tq9BegjOv6-iuDnUGPp6fNqvXrHh_Wa8ei0wTyfrMWOgNNtBiin1JLDaSSkQlExRKbbV2iPqUGBGOY5F7T3ONkEew9MSUhMzA_f7urgtfg4u9aqpoXV3r1oUhKiy4QDxngif07h-6DUPXpu8SlYIzRnGilnvKdiHGznm166pGd98KQTV6VKNHNXpUvx7Txu3h7mAaV_7xR3EJuNkD4-JxiiWEQlDyA3w-dSw</recordid><startdate>20230207</startdate><enddate>20230207</enddate><creator>Kim, Steven</creator><creator>Thal, Rebecca</creator><creator>Szkwarko, Daria</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20230207</creationdate><title>Management of Latent Tuberculosis Infection</title><author>Kim, Steven ; Thal, Rebecca ; Szkwarko, Daria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a385t-bc0fb2b0c242fd3c2b84814857408acaae14fae1537e6279ff49a11f10df3bd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antitubercular Agents - therapeutic use</topic><topic>Cardiovascular diseases</topic><topic>Estrogens</topic><topic>Humans</topic><topic>Latent Tuberculosis - drug therapy</topic><topic>Menopause</topic><topic>Mycobacterium tuberculosis</topic><topic>Night</topic><topic>Paroxetine</topic><topic>Signs and symptoms</topic><topic>Therapy</topic><topic>Tuberculosis</topic><topic>Venlafaxine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Steven</creatorcontrib><creatorcontrib>Thal, Rebecca</creatorcontrib><creatorcontrib>Szkwarko, Daria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Steven</au><au>Thal, Rebecca</au><au>Szkwarko, Daria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Latent Tuberculosis Infection</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2023-02-07</date><risdate>2023</risdate><volume>329</volume><issue>5</issue><spage>421</spage><epage>422</epage><pages>421-422</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><abstract>This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>36656598</pmid><doi>10.1001/jama.2022.24362</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2023-02, Vol.329 (5), p.421-422
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_miscellaneous_2767169576
source MEDLINE; American Medical Association Journals
subjects Antitubercular Agents - therapeutic use
Cardiovascular diseases
Estrogens
Humans
Latent Tuberculosis - drug therapy
Menopause
Mycobacterium tuberculosis
Night
Paroxetine
Signs and symptoms
Therapy
Tuberculosis
Venlafaxine
title Management of Latent Tuberculosis Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T05%3A53%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Latent%20Tuberculosis%20Infection&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Kim,%20Steven&rft.date=2023-02-07&rft.volume=329&rft.issue=5&rft.spage=421&rft.epage=422&rft.pages=421-422&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2022.24362&rft_dat=%3Cproquest_cross%3E2767169576%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2777765542&rft_id=info:pmid/36656598&rft_ama_id=2800774&rfr_iscdi=true